Is CVS Health Stock a Buy?
CVS Health (NYSE: CVS) isn't having a good year. It is facing multiple headwinds and slow revenue growth, and investors are reacting in kind. The company's shares are down by 26% since January.
CVS Health's issues didn't start in 2024, though, and that's the problem for the healthcare giant. It's much harder to ignore more than two years of poor performance. What exactly is going on with CVS Health? Can the company bounce back and still deliver solid returns over the long run?
Let's try to answer these questions.
Source Fool.com